Merck
CN
Search Within

367-29-3

应用筛选条件
关键词:'367-29-3'
显示 1-4 共 4 条结果 关于 "367-29-3" 范围 论文
Michael V Jaglal et al.
Leukemia research, 38(4), 443-446 (2014-01-21)
For patients with acute myeloid leukemia from antecedent myelodysplastic syndrome particularly after azanucleoside treatment failure, outcome is poor. Here, we conducted a case-control study in these patients to compare the efficacy of CLAG-M induction (28 patients) versus standard 3+7 induction
Filip Janku et al.
PloS one, 6(7), e22769-e22769 (2011-08-11)
Oncogenic mutations of PIK3CA, RAS (KRAS, NRAS), and BRAF have been identified in various malignancies, and activate the PI3K/AKT/mTOR and RAS/RAF/MEK pathways, respectively. Both pathways are critical drivers of tumorigenesis. Tumor tissues from 504 patients with diverse cancers referred to
Giuseppe De Luca et al.
Journal of cardiovascular medicine (Hagerstown, Md.), 21(6), 453-459 (2020-05-02)
Despite recent improvements in percutaneous coronary revascularization and antithrombotic therapies for the treatment of acute coronary syndromes, the outcome is still unsatisfactory in high-risk patients, such as the elderly and patients with diabetes. The aim of the current study was
Bergthor Björnsson et al.
World journal of gastroenterology, 21(6), 1775-1783 (2015-02-17)
To investigate whether nitrite administered prior to ischemia/reperfusion (I/R) reduces liver injury. Thirty-six male Sprague-Dawley rats were randomized to 3 groups, including sham operated (n = 8), 45-min segmental ischemia of the left liver lobe (IR, n = 14) and
1/1